As chancellor of the Exchequer Gordon Brown strives to fund his spending plans, British businesses are labouring under an increasingly aggressive anti-avoidance regime that is in danger of eroding UK competitiveness, writes AstraZeneca’s Ian Brimicombe.
Ian Brimicombe, 05 Oct 2005
